title: [NK activity and T cell subsets in percutaneous ethanol injection therapy of liver cancer--effect of lentinan with combined use].
authors.affiliation: Department of Medicine, Kawasaki Medical School.
authors.forename: S
authors.initials: S
authors.lastname: Yamamoto
authors.forename: K
authors.initials: K
authors.lastname: Takatori
authors.forename: K
authors.initials: K
authors.lastname: Ohmoto
authors.forename: S
authors.initials: S
authors.lastname: Ideguchi
authors.forename: R
authors.initials: R
authors.lastname: Yamamoto
authors.forename: T
authors.initials: T
authors.lastname: Ohumi
authors.forename: K
authors.initials: K
authors.lastname: Hino
authors.forename: Y
authors.initials: Y
authors.lastname: Hirano
mesh_terms: D000279:Administration, Cutaneous; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D000431:Ethanol / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D007912:Lentinan / Q000008:administration & dosage* / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000628:therapy*; D011134:Polysaccharides / Q000008:administration & dosage*; D013601:T-Lymphocytes / Q000145:classification*
chemical_list: D011134:Polysaccharides; D007912:Lentinan; D000431:Ethanol